Gynäkologie
Gynäkologische Onkologie
Urologie
Uroonkologie
Onkologie
Gynäkologische Onkologie
Uroonkologie
Sonstige Themen
Termin
20.
-
24.10.2023
Themen
- Integrating locoregional strategies into the management of metastatic breast cancer (mBC) patients
- First-line treatment of EGFR mutated NSCLC: Choosing between many options
- Is there still a place for anthracyclines in early breast cancer?
- HER2 positive gastroesophageal cancer
- Immunotherapy in colorectal cancer: Where do we stand and what do we expect?
- First-line therapy in advanced melanoma: What is my preferred choice?
- When does targeted therapy outperform immunotherapy in patients with advanced melanoma?
- East meets West in the management of head and neck cancer: Learning from each other (How to treat diseases with different risk factors and molecular alterations)
- When can we cure patients with metastatic sarcoma?
- Next generation diagnostics of blood cancer: An optimistic view on the future of cancer testing
- Is neoadjuvant immunotherapy a therapeutic platform for all tumour types?
- Bladder preservation strategies
- Biomarkers in metastatic colorectal cancer: What has changed in the last few years?
- Managing disease progression in oncogene-driven lung cancer
- Is stereotactic radiotherapy a valid alternative to surgery for patients with stage I NSCLC?
- Cutting edge diagnostics and innovation in the treatment of brain tumours
- Neoadjuvant and adjuvant therapy in genitourinary cancers
- Looking ahead in SCLC: From biology to clinical practice
- Artificial Intelligence in prognostication
- Cancer-related central and peripheral neuropathy
-
Adjuvant / neoadjuvant therapy of operable NSCLC in 2023
Veranstaltungsart
Vor Ort
Ort
IFEMA Madrid
Avda. Del Partenón, 5
28042 Madrid (E)
Wissenschaftliche Leitungen
Prof. Dr. Andrés Cervantes
Veranstalter
European Society for Medical Oncology (ESMO)
Via Ginevra 4
6900 Lugano (CH)
Tel.: +41 919731963
Fax: +41 919731918
Webseite der Veranstaltung